MACRILEN ACQUISITION AGREEMENT dated as of October 31, 2018 between NOVO NORDISK HEALTHCARE AG and STRONGBRIDGE BIOPHARMA PUBLIC LIMITED COMPANYMacrilen Acquisition Agreement • October 31st, 2018 • Strongbridge Biopharma PLC • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 31st, 2018 Company Industry JurisdictionMACRILEN ACQUISITION AGREEMENT (this “Agreement”) dated as of October 31, 2018 between Novo Nordisk Healthcare AG, a Swiss corporation (“Buyer”), and Strongbridge Biopharma Public Limited Company, an Irish public limited company (“Seller”).